Acute Rheumatic Carditis-API Insights, 2017
[Report Updated: 30-05-2017]

Published by Delve Insight: 30 May 2017 | 84090
Related Topics: FDA

Sorry, this report is no longer available.

We may have other suitable reports available - try Searching for Acute
or contact our sales team for personal assistance: phone +44 (0)7887945155 or email pdb@bioportfolio.co.uk.

Introduction

The active pharmaceutical ingredients worldwide market is in continuous development from the recent years. There is expected to be a major impact on the global API industry, with the large number of blockbuster drugs going off patent in the coming years. It is going to affect the revenue of the API market as generic drugs occupy the market.

India and China produce a large percentage of a majority of the APIs and intermediates produced in the world currently. The USFDA and EMA have strict guidelines for API manufacturing 'Process Validation: General Principles and Practices'. While countries such as Japan and Singapore are signatories to the ICH Q7 regulation, India and China follow their national GMP guidelines. The efficiency and expertise of Asian contract manufacturers have positioned them in a very strategic space in the global pharmaceutical supply chain, with a vast majority of the APIs and intermediates being sourced from markets such as India and China.

DelveInsight’s, Acute Rheumatic Carditis -API Insights, 2017 Report describes the current therapeutics that are propelling the pharmaceutical markets worldwide. The report gives the clear idea on the United States Drug Master File (USDMF) and Europe DMF filed by worldwide countries related to the Acute Rheumatic Carditis. It also provides the India and China API Manufactures who are driving the current API Market. The report also highlights the patent and patent exclusivity information. The research analysis also presents the global sales data till 2016.

Data Sources

The report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by DelveInsight team of industry experts. Secondary sources information and data has been collected from various printable and non-printable sources like search engines, News websites, Government Websites, Trade Journals, White papers, Magazines, Trade associations, Books, Industry Portals, Industry Associations and access to available databases.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

• A snapshot of the global Market therapeutics scenario for Acute Rheumatic Carditis.

• A review of the marketed products under prescription for Acute Rheumatic Carditis, regulatory information and marketing status.

• Coverage of global patent coverage and detailed commentaries on the US patent challenges.

• Graphical representation of investigational products for patent expiry and market exclusivities across the globe.

• Product profiles for marketed products for Acute Rheumatic Carditis with complete description of mechanism of action, therapeutic class, target, route(s) of administration and chemical details.

• Coverage of API Manufacturers for Acute Rheumatic Carditis drugs in the United States, Europe and Asian Regions with location details.

• Coverage of Regulatory filings in the US, Europe, and Asia specifically India and China for Acute Rheumatic Carditis drugs.

• Key discontinued Marketed products.

• Global Sales Figure from 2012-2016.Reasons to Buy

• Evaluate the marketing status and exclusivity details of Acute Rheumatic Carditis key products to exploit opportunities for generic drug development opportunities.

• Key players in the pharmaceutical industry.

•Strategic drivers and restraints of this market are revealed and market opportunities and challenges are identified.

• Design effective counter-strategies to gain competitive advantage by identifying the key patent expiry details and exclusivity with respect to Acute Rheumatic Carditis.

• API intelligence over marketed drugs for Acute Rheumatic Carditis and gaining primary intelligence over active ingredients manufacturers across the globe.

• Uncovering opportunities in the rapidly growing the US markets.

Table of Contents
for Acute Rheumatic Carditis-API Insights, 2017 [Report Updated: 30-05-2017]

List Of Tables
in Acute Rheumatic Carditis-API Insights, 2017 [Report Updated: 30-05-2017]

Acute Rheumatic Carditis Therapeutic Market, US, Marketed Drugs by Application Type, 2017

Acute Rheumatic Carditis Therapeutic Market, US, Marketed Drugs by Marketing Status, 2017

Acute Rheumatic Carditis Therapeutic Market, US, (Year), 2017

Acute Rheumatic Carditis Marketed Drugs, API Manufacturers by US DMF Status, 2017

Acute Rheumatic Carditis Marketed Drugs, US DMF Status Drug Specific (Number), 2017

Acute Rheumatic Carditis Therapeutic Market, Global Sales (in million USD), 2017

Acute Rheumatic Carditis Marketed Drugs, API Manufacturers, Global, 2017

Discontinued Drugs for Acute Rheumatic Carditis, 2017

List Of Figures, Charts and Diagrams
in Acute Rheumatic Carditis-API Insights, 2017 [Report Updated: 30-05-2017]

Acute Rheumatic Carditis Therapeutic Market, US, Marketed Drugs by Application Type (%), 2017

Acute Rheumatic Carditis Therapeutic Market, US, Marketed Drugs by Marketing Status (%), 2017

Acute Rheumatic Carditis Therapeutic Market, US, (Year), 2017

Acute Rheumatic Carditis Marketed Drugs, API Manufacturers by US DMF Status (%), 2017

Acute Rheumatic Carditis Marketed Drugs, US DMF Status Drug Specific (Number), 2017

Acute Rheumatic Carditis Therapeutic Market, Global Sales (in million USD), 2017

Acute Rheumatic Carditis Marketed Drugs, Patent/Exclusivity Expiry (Year), 2017

Additional Details

Publisher

Delve Insight

Publisher Information

DelveInsight is a leading Business Consulting and Market Research Firm. We combine industry expertise with probing market insights in innovative ways to deliver enduring results to deliver critical information to leading decision makers.



We help our clients to find answers relevant to their business, facilitating decision-making; identify potential market opportunities, competitor assessments and business environmental assessment. DelveInsight is a knowledge partner for business strategy and market research across the drug value chain.

Reference

84090 | DII2017API012

Number of Pages

60

Report Format

PDF

Delve Insight Reports

Related Reports

TitleDate PublishedPrice fromMore Details
Global Acute and Chronic Myelogenous Leukemia Partnering 2010 to 2016
The Global Therapy Partnering Terms and Agreements since 2010 report provides understanding and acce...
01 Oct 2016 by Current Partnering USD $1,495 More Info
Acute Renal Failure (ARF) (Acute Kidney Injury) Global Clinical Trials Review, H1, 2016
Acute Renal Failure (ARF) (Acute Kidney Injury) Global Clinical Trials Review, H1, 2016SummaryGlobal...
20 Apr 2016 by Global Data USD $2,500 More Info
Acute Pain Global Clinical Trials Review, H1, 2016
Acute Pain Global Clinical Trials Review, H1, 2016SummaryGlobalData's clinical trial report, “Acute ...
20 Apr 2016 by Global Data USD $2,500 More Info
Acute Respiratory Distress Syndrome Global Clinical Trials Review, H1, 2016
Acute Respiratory Distress Syndrome Global Clinical Trials Review, H1, 2016SummaryGlobalData's clini...
29 Feb 2016 by Global Data USD $2,500 More Info
Acute Stress Disorder Global Clinical Trials Review, H2, 2015
Acute Stress Disorder Global Clinical Trials Review, H2, 2015SummaryGlobalData's clinical trial repo...
16 Dec 2015 by Global Data USD $2,500 More Info
Acute Injury Global Clinical Trials Review, H2, 2015
Acute Injury Global Clinical Trials Review, H2, 2015SummaryGlobalData's clinical trial report, “Acut...
09 Dec 2015 by Global Data USD $2,500 More Info
Acute Respiratory Failure Global Clinical Trials Review, H2, 2015
Acute Respiratory Failure Global Clinical Trials Review, H2, 2015SummaryGlobalData's clinical trial ...
25 Nov 2015 by Global Data USD $2,500 More Info
Acute and Sub-Acute Bursitis Global Clinical Trials Review, H2, 2015
Acute and Sub-Acute Bursitis Global Clinical Trials Review, H2, 2015SummaryGlobalData's clinical tri...
25 Nov 2015 by Global Data USD $2,500 More Info
Altitude Sickness (Acute mountain sickness) Global Clinical Trials Review, H2, 2015
Altitude Sickness (Acute mountain sickness) Global Clinical Trials Review, H2, 2015SummaryGlobalData...
25 Nov 2015 by Global Data USD $2,500 More Info
Acute Upper Respiratory Tract Infections Global Clinical Trials Review, H2, 2015
Acute Upper Respiratory Tract Infections Global Clinical Trials Review, H2, 2015SummaryGlobalData's ...
30 Oct 2015 by Global Data USD $2,500 More Info

This report is published by Delve Insight

DelveInsight is a leading Business Consulting and Market Research Firm. We combine industry expertise with probing market insights in innovative ways to deliver enduring results to deliver critical information to leading decision makers.

We help our clients to find answers relevant to their business, facilitating decision-making; identify potential market opportunities, competitor assessments and business environmental assessment. DelveInsight is a knowledge partner for business strategy and market research across the drug value chain.

We Stock...